cinrebafusp alfa
pieris pharmaceuticals,servier
['prs-343']
$pirs pieris pharmaceuticals announces presentation of positive clinical data for cinrebafusp alpa (prs-343) at 2023 aacr annual meeting 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities